Company Website:
http://lundinlawpc.com
LOS ANGELES -- (Business Wire)
Lundin
Law PC, a shareholder rights firm, announces a class action lawsuit
has been filed against Taro Pharmaceutical Industries (“Taro” or the
“Company”) (NYSE: TARO) concerning possible violations of federal
securities laws between July 3, 2014 and September 9, 2016 (the “Class
Period”). Investors who purchased or otherwise acquired shares during
the Class Period should contact the Firm prior to the December 26,
2016 lead plaintiff motion deadline.
To participate in this class action lawsuit, click
here. You can also call Brian Lundin, Esquire, of Lundin Law PC,
at 888-713-1033, or e-mail him at brian@lundinlawpc.com.
No class has been certified in the above action. Until a class is
certified, you are not considered represented by an attorney. You may
also choose to do nothing and be an absent class member.
According to the complaint, Taro made false and/or misleading statements
and/or failed to disclose that: since 2014 the Company has worked with
other pharmaceutical companies to keep the price of generic products
artificially high; that the foregoing behavior violated federal
antitrust laws; that Taro’s revenues during the Class Period were the
result of illegal conduct; and that as a result of the above, the
Company’s public statements were materially false and misleading at all
relevant times. On September 9, 2016, the Company announced that its
subsidiary and two senior officers received grand jury subpoenas from
the U.S. Department of Justice, Antitrust Division, seeking documents
regarding the sale of generic pharmaceutical products. Then on October
17, 2016, NECA-IBEW Welfare Trust Fund filed an antitrust class action
lawsuit against Taro and several other pharmaceutical companies alleging
involvement in the price-fixing of Clobetasol since 2014.
Lundin Law PC was founded by Brian Lundin, a securities litigator based
in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161026006959/en/
Contacts:
Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile:
888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/
Source: Lundin Law PC
© 2024 Canjex Publishing Ltd. All rights reserved.